StoneX Group’s Biotricity, Inc. Common Stock BTCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,827
Closed -$32K 612
2021
Q3
$32K Buy
+1,827
New +$34.3K ﹤0.01% 462

Other funds holding BTCY

StoneX Group's BTCY Position: Q4 2021 in Review

StoneX Group sold out of Biotricity, Inc. Common Stock (BTCY) in Q4 2021, closing a stake of 1,827 shares — an estimated $32K sold.

StoneX Group first reported a position in BTCY in Q3 2021 and held it in 1 quarter. The position peaked at $32K in Q3 2021. 29 funds tracked by Wall St. Rank hold BTCY as of Q4 2021.

  • StoneX Group reported no remaining Biotricity, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • StoneX Group sold 1,827 Biotricity, Inc. Common Stock shares in Q4 2021, an estimated $32K.
  • StoneX Group first reported a position in Biotricity, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • StoneX Group's Biotricity, Inc. Common Stock position peaked at $32K in Q3 2021.
  • 29 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q4 2021.

Based on StoneX Group's 13F filing for Q4 2021, filed 10 Feb 2022.